13D Filing: Tang Capital Partners LP and Cyclacel Pharmaceuticals Inc. (CYCC)

Page 4 of 7 – SEC Filing

CUSIP NO. 23254L405
13D
Page 4 of 7
1.
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Kevin C. Tang
2.
Check the Appropriate Box if a Member of a Group
(a) ¨
(b) ý
3.
SEC Use Only
4.
Source of Funds
WC
5.
Check If Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e)
o
6.
Citizenship or Place of Organization
United States
Number of
Shares Beneficially
Owned by
Each Reporting
Person With
7.
Sole Voting Power
0
8.
Shared Voting Power
336,747
9.
Sole Dispositive Power
0
10.
Shared Dispositive Power
336,747
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
336,747
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares           ¨
13.
Percent of Class Represented by Amount in Row (11)
2.8%
14
Type of Reporting Person
IN

Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC)